Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia

Prenatal Diagnosis

Volumn 27, Issue 13, 2007, Pages 1212-1218

  Tsui, Dana W Y ^a   Chan, K C Allen ^a   Chim, Stephen S C ^a   Chan, Lin Wai ^a   Leung, Tak Yeung ^a   Lau, Tze Kin ^a   Lo, Y M Dennis ^a   Chiu, Rossa W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Circulating foetal nucleic acids; DNA methylation; Epigenetics; Non invasive prenatal diagnosis; Pre eclampsia; RASSF1A

Indexed keywords

BETA ACTIN; DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ARTICLE; CONTROLLED STUDY; DNA HYPERMETHYLATION; DNA METHYLATION; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEX DIFFERENCE; THIRD TRIMESTER PREGNANCY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; MALE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 37349014758     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1897     Document Type: Article

References (33)

1. Agathanggelou A, Cooper WN, Latif F. 2005. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer 65: 3497-3508.
2. Angert RM, LeShane ES, Lo YMD, Chan LY, Delli-Bovi LC, Bianchi DW. 2003. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first-and third-trimester samples. Clin Chem 49: 195-198.
3. Azhikina TL, Sverdlov ED. 2005. Study of tissue-specific CpG methylation of DNA in extended genomic loci. Biochemistry (Mosc) 70: 596-603.
4. Bianchi DW. 2004. Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta 25(Suppl. A): S93-S101.
5. Chan KCA, Ding CM, Gerovassili A, et al. 2006. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52: 2211-2218.
6. Chim SSC, Tong YK, Chiu RWK, et al. 2005. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 102: 14753-14758.
7. Chiu RWK, Lau TK, Leung TN, Chow KC, Chui DH, Lo YMD. 2002. Prenatal exclusion of beta-thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
8. Chiu RWK, Poon LL, Lau TK, et al. 2001. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 47: 1607-1613.
9. Chiu RWK, Chim SSC, Wong IH, et al. 2007. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 170: 941-950.
10. DiFederico E, Genbacev O, Fisher SJ. 1999. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155: 293-301.
11. Emlen W, Mannik M. 1984. Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol 56: 185-192.
12. Faas BHW, Beuling EA, Christiaens GC, Von Dem Borne AE, Van Der Schoot CE. 1998. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352: 1196.
13. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. 2004. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 24: 722-726.
14. Frommer M, McDonald LE, Millar DS, et al. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827-1831.
15. Grunau C, Clark SJ, Rosenthal A. 2001. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 29: E65-E65.
16. Herman JG, Jen J, Merlo A, Baylin SB. 1996. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56: 722-727.
17. Hesson LB, Cooper WN, Latif F. 2007. The role of RASSF1A methylation in cancer. Dis Markers 23: 73-87.
18. Lau TW, Leung TN, Chan LY, et al. 2002. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 48: 2141-2146.
19. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YMD. 1998. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352: 1904-1905.
20. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. 2001a. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184: 1249-1250.
21. Leung TN, Zhang J, Lau TK, Chan LY, Lo YMD. 2001b. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47: 137-139.
22. Levine RJ, Qian C, Leshane ES, et al. 2004. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 190: 707-713.
23. Lo YMD, Chiu RWK. 2007. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 8: 71-77.
24. Lo YMD, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
25. Lo YMD, Hjelm NM, Fidler C, et al. 1998a. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 1734-1738.
26. Lo YMD, Tein MS, Lau TK, et al. 1998b. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775.
27. Lo YMD, Leung TN, Tein MS, et al. 1999. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45: 184-188.
28. Lui YY, Chik KW, Chiu RWK, Ho CY, Lam CW, Lo YMD. 2002. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48: 421-427.
29. Lun FFM, Chiu RWK, Leung TY, Leung TN, Lau TK, Lo YMD. 2007. Epigenetic analysis of RASSF1A gene in cell-free DNA in amniotic fluid. Clin Chem 53: 796-798.
30. Redman CW, Sargent IL. 2005. Latest advances in understanding preeclampsia. Science 308: 1592-1594.
31. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. 2002. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 48: 650-653.
32. Tsumita T, Iwanaga M. 1963. Fate of injected deoxyribonucleic acid in mice. Nature 198: 1088-1089.
33. Zhong XY, Laivuori H, Livingston JC, et al. 2001. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184: 414-419.